featured

A Rwandan Pharmaceutical Receives €2 Million for Vaccine Development

Akagera Medicines Africa Limited, a Rwandan pharmaceutical company, has secured €2 million in financing…

Kigali Heights Bought, Investor to Announce Transaction Details Today

A significant buyout announcement is expected today from the Kigali Heights Development Company, with…

Rwanda Administers 669 Marburg Vaccine Doses, Reports Two Recoveries

Rwanda’s vaccination campaign against the Marburg virus disease (MVD) continues, with a total of…